Banque Cantonale Vaudoise’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $891K | Sell |
18,310
-269
| -1% | -$13.1K | 0.04% | 371 |
|
|
2025
Q1 | $632K | Buy |
+18,579
| New | +$632K | 0.03% | 425 |
|
|
2024
Q3 | $804K | Sell |
17,111
-265
| -2% | -$12.5K | 0.03% | 346 |
|
|
2024
Q2 | $939K | Buy |
17,376
+782
| +5% | +$42.3K | 0.04% | 353 |
|
|
2024
Q1 | $1.13M | Buy |
16,594
+458
| +3% | +$31.2K | 0.04% | 334 |
|
|
2023
Q4 | $1.01M | Sell |
16,136
-72
| -0.4% | -$4.51K | 0.04% | 341 |
|
|
2023
Q3 | $736K | Sell |
16,208
-158
| -1% | -$7.18K | 0.04% | 385 |
|
|
2023
Q2 | $918K | Buy |
16,366
+692
| +4% | +$38.8K | 0.04% | 367 |
|
|
2023
Q1 | $709K | Sell |
15,674
-98
| -0.6% | -$4.43K | 0.03% | 375 |
|
|
2022
Q4 | $641K | Buy |
15,772
+133
| +0.9% | +$5.41K | 0.03% | 397 |
|
|
2022
Q3 | $1.02M | Sell |
15,639
-205
| -1% | -$13.4K | 0.06% | 322 |
|
|
2022
Q2 | $963K | Buy |
15,844
+11,615
| +275% | +$706K | 0.05% | 351 |
|
|
2022
Q1 | $266K | Buy |
4,229
+786
| +23% | +$49.4K | 0.01% | 720 |
|
|
2021
Q4 | $261K | Sell |
3,443
-623
| -15% | -$47.2K | 0.01% | 761 |
|
|
2021
Q3 | $455K | Sell |
4,066
-297
| -7% | -$33.2K | 0.02% | 584 |
|
|
2021
Q2 | $706K | Sell |
4,363
-360
| -8% | -$58.3K | 0.03% | 511 |
|
|
2021
Q1 | $575K | Sell |
4,723
-5,559
| -54% | -$677K | 0.03% | 497 |
|
|
2020
Q4 | $1.58M | Buy |
10,282
+1,310
| +15% | +$201K | 0.09% | 206 |
|
|
2020
Q3 | $751K | Buy |
8,972
+308
| +4% | +$25.8K | 0.05% | 329 |
|
|
2020
Q2 | $637K | Buy |
8,664
+833
| +11% | +$61.2K | 0.05% | 329 |
|
|
2020
Q1 | $332K | Sell |
7,831
-758
| -9% | -$32.1K | 0.03% | 478 |
|
|
2019
Q4 | $523K | Buy |
+8,589
| New | +$523K | 0.04% | 448 |
|